O-33 Is the difference between tamoxifen and anastrozole in adjuvant trials applicable for primary endocrine therapy of early operable primary breast cancer in the elderly?

Authors :: K.L. Cheung
Amit Agrawal
M. Ying
L. Winterbottom
Ian O. Ellis
D.A.L. Morgan
Source :: European Journal of Cancer Supplements. 5:11
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Primary (chemistry)
business.industry
Endocrine therapy
Anastrozole
medicine.disease
Adjuvant Trials
Breast cancer
Internal medicine
Medicine
business
Primary breast cancer
Tamoxifen
medicine.drug

Tools